Kazia Therapeutics (KZIA) Profit After Tax (2009 - 2013)

Kazia Therapeutics has reported Profit After Tax for 5 years, with the latest figure at -$1.4 million in Q3 2013.

• For the quarter ending Q3 2013, Profit After Tax changed N/A year-over-year to -$1.4 million; the trailing twelve-month figure through Aug 2013 stood at -$27.6 million (changed N/A YoY), and the FY2025 full-year result was -$13.3 million, up 24.88% from the prior year.
• Profit After Tax for Q3 2013 stood at -$1.4 million, up from -$1.5 million in the prior quarter.
• The five-year high for Profit After Tax was -$1.4 million in Q3 2013, with the low at -$21.6 million in Q4 2009.
• Historically, Profit After Tax has averaged -$9.8 million across 5 years, with a median of -$9.6 million in 2011.
• Annual changes were most pronounced in 2010 — Profit After Tax soared 30.36% — and 2012, when it jumped 84.06%.
• Kazia Therapeutics' Profit After Tax stood at -$21.6 million in 2009, then jumped by 30.36% to -$15.1 million in 2010, then soared by 36.35% to -$9.6 million in 2011, then jumped by 84.06% to -$1.5 million in 2012, then rose by 8.91% to -$1.4 million in 2013.
• The last three Profit After Tax figures came in at -$1.4 million (Q3 2013), -$1.5 million (Q4 2012), and -$9.6 million (Q4 2011), per Business Quant data.